Atsushi Akahane

Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-<i>a</i>]pyridin-3-yl)-1(6<i>H</i>)-pyridazinebutanoic Acid (FK 838):  A Novel Non-Xanthine Adenosine A₁Receptor Antagonist with Potent Diuretic Activity

Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga et al. · Journal of Medicinal Chemistry · 1999 · 102 citations · Full text

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Takuya Maemoto, Miho Tada, Takuma Mihara et al. · Journal of Pharmacological Sciences · 2004 · 78 citations · Full text

Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition

Takuma Mihara, Kayoko Mihara, Junko Yarimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 75 citations

Pharmacological Characterization of a Simple Behavioral Response Mediated Selectively by Central Adenosine A1 Receptors, Using In Vivo and In Vitro Techniques

Hugh Marston, Keith Finlayson, Takuya Maemoto et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 62 citations

Species differences in brain adenosine A₁ receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists

Takuya Maemoto, Keith Finlayson, Henry J. Olverman et al. · British Journal of Pharmacology · 1997 · 58 citations · Full text